-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IUhgwGbKsoHTuh6J8CB1jHlLUW7didcX2+vDkZNoPYuDs4wagXYMEkCn8AMNNK0v AYYQtiKxsBNjyvhSc4TirA== 0000024741-96-000010.txt : 19960213 0000024741-96-000010.hdr.sgml : 19960213 ACCESSION NUMBER: 0000024741-96-000010 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960212 SROS: NYSE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CORNING INC /NY CENTRAL INDEX KEY: 0000024741 STANDARD INDUSTRIAL CLASSIFICATION: GLASS, GLASSWARE, PRESSED OR BLOWN [3220] IRS NUMBER: 160393470 STATE OF INCORPORATION: NY FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-19283 FILM NUMBER: 96515326 BUSINESS ADDRESS: STREET 1: ONE RIVERFRONT PLAZA CITY: CORNING STATE: NY ZIP: 14831 BUSINESS PHONE: 6079749000 FORMER COMPANY: FORMER CONFORMED NAME: CORNING INC /NY / CORNING LAB SERVICES INC DATE OF NAME CHANGE: 19930713 FORMER COMPANY: FORMER CONFORMED NAME: CORNING GLASS WORKS DATE OF NAME CHANGE: 19890512 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CORNING INC /NY CENTRAL INDEX KEY: 0000024741 STANDARD INDUSTRIAL CLASSIFICATION: GLASS, GLASSWARE, PRESSED OR BLOWN [3220] IRS NUMBER: 160393470 STATE OF INCORPORATION: NY FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: ONE RIVERFRONT PLAZA CITY: CORNING STATE: NY ZIP: 14831 BUSINESS PHONE: 6079749000 FORMER COMPANY: FORMER CONFORMED NAME: CORNING INC /NY / CORNING LAB SERVICES INC DATE OF NAME CHANGE: 19930713 FORMER COMPANY: FORMER CONFORMED NAME: CORNING GLASS WORKS DATE OF NAME CHANGE: 19890512 SC 13G 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 ___________________________________________________________ SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2) UNILAB CORPORATION (Name of Issuer) Common Stock, par value $.01 (Title of Class of Securities) 904763-10-9 (CUSIP Number) Raymond C. Marier, Esq. Corning Clinical Laboratories Inc. (formerly known as MetPath Inc.) One Malcolm Avenue Teterboro, NJ 07608 Telephone: (201) 393-5000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) Check the following box if a fee is being paid with this statement ________. CUSIP No. 904763-10-9 (1) Name of Reporting Person S. S. or I.R.S. Identification No. of Above Person Corning Incorporated I.R.S. Identification No.: 16-0393470 (2) Check the Appropriate Box if a Member of a Group (See Instructions) ___ (a) ___________________________________________________ _X__ (b) ___________________________________________________ ___________________________________________________ (3) SEC Use Only ___________________________________________ ________________________________________________________ (4) Citizenship or Place of Organization: __New York________ ________________________________________________________ ____________ Number of (7) Sole Voting Power Corning Clinical Shares Laboratories Inc. 1,044,840 (1); Corning Beneficially Incorporated - 0 Owned by (8) Shared Voting Power_______0__________ Each _____________________________________ Reporting (9) Sole Dispositive Power Corning Clinical Person Laboratories Inc. 1,044,840 (1); Corning With Incorporated -0 ____________ (10) Shared Dispositive Power _0__________ (9) Aggregate Amount Beneficially Owned by Each Reporting Person 1,044,840 (1) shares of Common Stock by Corning Clinical Laboratories Inc. (10) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) __________________________________ ____________________________________________________________ (11) Percent of Class Represented by Amount in Row (11) _________ ___________________Less than 5%_______________________ (12) Type of Reporting Person (See Instructions) ____HC__________ - ----- (1) This figure includes 20,000 shares of Common Stock that Corning Clinical Laboratories Inc. has a right to purchase pursuant to options/warrants issued to it by the issuer. CUSIP No. 904763-10-9 (1) Name of Reporting Person S. S. or I.R.S. Identification No. of Above Person Corning Clinical Laboratories Inc. I.R.S. Identification No.: 16-1387862 (2) Check the Appropriate Box if a Member of a Group (See Instructions) ___ (a) ___________________________________________________ _X__ (b) ___________________________________________________ ___________________________________________________ (3) SEC Use Only ___________________________________________ ________________________________________________________ (4) Citizenship or Place of Organization: __Delaware________ ________________________________________________________ ____________ Number of (7) Sole Voting Power Corning Clinical Shares Laboratories Inc. 1,044,840 (1); Corning Beneficially Incorporated - 0 Owned by (8) Shared Voting Power_______0__________ Each _____________________________________ Reporting (9) Sole Dispositive Power Corning Clinical Person Laboratories Inc. 1,044,840 (1); Corning With Incorporated -0 ____________ (10) Shared Dispositive Power _0__________ (9) Aggregate Amount Beneficially Owned by Each Reporting Person 1,044,840 (1) shares of Common Stock by Corning Clinical Laboratories Inc. (10) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) __________________________________ ____________________________________________________________ (11) Percent of Class Represented by Amount in Row (11) _________ ___________________Less than 5%_______________________ (12) Type of Reporting Person (See Instructions) ____CO_________ - ----- (1) This figure includes 20,000 shares of Common Stock that Corning Clinical Laboratories Inc. has a right to purchase pursuant to options/warrants issued to it by the issuer. Item 1. Issuer This statement on Schedule 13G (this "Statement") relates to the common stock, par value $.01 per share, of Unilab Corporation (the "Issuer"), a Delaware corporation with its principal offices located at 18448 Oxnard Street, Tarzana, CA 91356. Item 2. Person Filing and Securities This Statement is being filed by Corning Incorporated, a New York corporation ("Corning"), with its principal business office located at One Riverfront Plaza, Corning, NY 14831, and by Corning Clinical Laboratories Inc., a Delaware corporation formerly known as MetPath Inc. ("CCL"), with its principal business office located at One Malcolm Avenue, Teterboro, NJ 07608. The class of equity securities to which this Statement relates is the Common Stock, par value $.01 per share (the "Common Stock") of the Issuer (CUSIP 904763-10-9) Item 3. Person Filing Pursuant to Rule 13d-1(b) or 13d-2(b) Not applicable. Item 4. Ownership. Corning is a publicly owned corporation and beneficially owns shares of Common Stock through its wholly owned subsidiary, CCL. As of December 31, 1995 CCL beneficially owned 1,044,840 shares of Common Stock consisting of (i) 1,024,840 shares owned and (ii) immediately exercisable options to purchase 20,000 shares at $2.00 per share, expiring March 8, 2000. Based on the number of shares of Common Stock outstanding as of October 27, 1995 (34,923,924 according to the Issuer), the aggregate number of 1,044,840 shares of Common Stock beneficially owned by CCL would constitute approximately 3% of the outstanding shares of Common Stock. CCL has the sole power to vote and dispose of the Common Stock which it beneficially owns. CCL also holds 300,000 shares of non-voting convertible preferred stock of Issuer, redeemable at the sole option of Issuer any time from and after November 10, 1998. Item 5. Ownership of Five Percent or Less of a Class Not applicable. Item 6. Ownership of More Than Five Percent on Behalf of Another Person Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company Not applicable. Item 8. Identification and Classification of Members of the Group Not applicable. Item 9. Notice of Dissolution of Group Not applicable. Item 10. Certification Not applicable. SIGNATURE After reasonable inquiry and to the best knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this statement is true, complete and correct. CORNING CLINICAL LABORATORIES INC. Date: February 12, 1996 By: /s/ Leo C. Farrenkopf, Jr. Name: Leo C. Farrenkopf, Jr. Title: Assistant Secretary Associate General Counsel SIGNATURE After reasonable inquiry and to the best knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this statement is true, complete and correct. CORNING INCORPORATED Date: February 12, 1996 By /s/ A. John Peck Name: A. John Peck Title: Secretary -----END PRIVACY-ENHANCED MESSAGE-----